These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 7537949
1. Granulocyte colony stimulating factor significantly influences neutrophil recovery and duration of hospitalisation in bone marrow transplantation. Teoh GK, Tan PH, Goh YT. Ann Acad Med Singap; 1994 Nov; 23(6):823-7. PubMed ID: 7537949 [Abstract] [Full Text] [Related]
2. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Schmitz N, Dreger P, Zander AR, Ehninger G, Wandt H, Fauser AA, Kolb HJ, Zumsprekel A, Martin A, Hecht T. Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668 [Abstract] [Full Text] [Related]
7. Severe bactrim-induced neutropenia with reversal of CD4+/CD8+ lymphocyte ratio: response to recombinant human granulocyte-colony stimulating factor (R-metHUG-CSF). Krishnan K, Krishnaswamy G. Clin Lab Haematol; 1998 Jun; 20(3):187-8. PubMed ID: 9681236 [Abstract] [Full Text] [Related]
8. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. Farese AM, Hunt P, Grab LB, MacVittie TJ. J Clin Invest; 1996 May 01; 97(9):2145-51. PubMed ID: 8621805 [Abstract] [Full Text] [Related]
9. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F. Cancer Chemother Pharmacol; 1997 May 01; 39(3):259-66. PubMed ID: 8996530 [Abstract] [Full Text] [Related]
11. Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer. Kennedy MJ, Davis J, Passos-Coelho J, Noga SJ, Huelskamp AM, Ohly K, Davidson NE. Cancer Res; 1993 Nov 15; 53(22):5424-8. PubMed ID: 7693341 [Abstract] [Full Text] [Related]
14. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation. Cioch M, Jawniak D, Kotwica K, Wach M, Mańko J, Gorący A, Klimek P, Mazurkiewicz E, Jarosz P, Hus M. Transplant Proc; 2014 Oct 15; 46(8):2882-4. PubMed ID: 25380941 [Abstract] [Full Text] [Related]
19. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G. Bone Marrow Transplant; 1996 Jan 15; 17(1):31-7. PubMed ID: 8673051 [Abstract] [Full Text] [Related]